Aurora Cannabis Reports Q2 Revenue of CA$86.0 Million
Aurora Cannabis announced its second-quarter financial results, reporting revenue of CA$86.0 million, which exceeded analyst expectations.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Aurora Cannabis announced its second-quarter financial results, reporting revenue of CA$86.0 million, which exceeded analyst expectations.
Organigram Global Inc. has entered into an arrangement agreement to acquire Aurora Cannabis Inc. for C$7.80 per share, valuing the company at approximately C$561 million.
The Canadian Investment Regulatory Organization (CIRO) implemented a temporary trading halt on Aurora Cannabis Inc. (TSX: ACB) on November 3, 2026, pending the release of company news.
The Alberta Securities Commission has ruled in favor of Aurora Cannabis, dismissing an application by Curaleaf Holdings that challenged the company's At-the-Market (ATM) program.
Curaleaf condemns Aurora Cannabis for rejecting its enhanced proposal, accusing the board of obstructing engagement and fair value.